Citations 139

Antineutrophil cytoplasmic antibody–associated vasculitis and VEXAS syndrome: comment on the article by Muratore et al

Arthritis & Rheumatology | January 30, 2023 | Volume: 75 | Issue: 8 | Pages: 1490-1492

10.1002/art.42466 | PMID 36716119

Efficacy of MEK Inhibitors in Erdheim Chester Disease

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9733-9734

10.1182/blood-2022-163674

Clonal Hematopoiesis in Vexas Syndrome

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 5745-5746

10.1182/blood-2022-160263

High Prevalence of Epigenetic Mutations in Histiocytic and Dendritic Cell Disorders: Results from Molecular Analysis of a Large Cohort from Histiocytosis Working Group

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 32-33

10.1182/blood-2022-162855

Monocytopenia As an Adverse Prognosticator in Vexas Syndrome

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 11406-11407

10.1182/blood-2022-165706

DNMT3A/TET2 Mutant Clonal Hematopoiesis in Vexas Syndrome Results in DNA Hypomethylation and Transcriptional Activation of WT1 and MPL Oncogenic Pathways

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 11410-11411

10.1182/blood-2022-167359

Mutational Profiling of Rosai-Dorfman Disease and Association with Phenotype: A Multi-Institutional Study

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3995-3996

10.1182/blood-2022-159714

Nitrofurantoin and Minocycline–Associated Vasculitic Neuropathy: Case Reports and Literature Review

Journal of Clinical Neuromuscular Disease | November 21, 2022 | Volume: 24 | Issue: 2 | Pages: 85-94

10.1097/cnd.0000000000000404 | PMID 36409339

Abstract Background: Vasculitic neuropathies usually present acutely to subacutely, with an asymmetric pattern, involving multiple peripheral nerve territories. Drug-induced vasculitis is an often overlooked etiology of vasculitic neuropathy. Methods: We present the first reported case of nitrofurantoin-associated and an illustrative case of minocycline-associated vasculitic neuropathy, with a review of the literature. Results: The first patient is a 60-year-old woman who developed axonal sensorimotor peripheral neuropathy after nitrofurantoin use, with a superficial radial nerve biopsy confirming vasculitis. The second patient is a 23-year-old woman, with a history of acne vulgaris treated with minocycline, who presented with a subacute right common peroneal mononeuropathy followed by a left deep peroneal mononeuropathy, with elevated antinuclear, perinuclear-antineutrophil cytoplasmic, and myleoperoxidase antibodies, and MPO titers, and a sural nerve biopsy showing large arteriole vasculitis. Finally, we provide a comprehensive review of previously published cases. Conclusions: Medications should be considered as a trigger for medication-induced vasculitic neuropathy. Accurate diagnosis would ensure timely treatment.
Reduced intensity conditioning allogeneic hematopoietic stem cell transplantation in VEXAS syndrome: Data from a prospective series of patients

American Journal of Hematology | November 20, 2022 | Volume: 98 | Issue: 2 | Pages: No page available

10.1002/ajh.26786 | PMID 36403135

Exploring Gene Expression Profiles in Primary Central Nervous System Vasculitis

Annals of Neurology | October 20, 2022 | Volume: 93 | Issue: 1 | Pages: 120-130

10.1002/ana.26537 | PMID 36264136

ObjectiveThis study was undertaken to explore the gene expression profile of primary central nervous system vasculitis (PCNSV).MethodsBrain specimens of 4 patients with granulomatous vasculitis (GV), 5 with lymphocytic vasculitis (LV), 4 with amyloid β‐related angiitis (ABRA), and 4 normal controls were studied. RNA‐sequencing was performed using the Illumina Hiseq‐4,000 platform and the Illumina TruSeq Total‐RNA library. Student t test and false discovery rate tests were performed for each of the differentially expressed transcripts. Ingenuity Pathway Analysis was used for the pathway expression analysis. CIBERSORT was used to estimate the abundances of different immune cell subsets in the tissues based on gene expression data.ResultsTranscripts differentially expressed between PCNSV and normal brain indicated that endosomal, mitochondrial, and ribosome dysfunction, alterations in protein synthesis, and noncoding RNAs might be involved in PCNSV. Pathway analysis revealed the activation of dendritic cell maturation and antigen processing as well as neuroinflammation in PCNSV versus normal brain, whereas oxidative phosphorylation was inhibited. CIBERSORT estimation of immune cell subsets suggested that activated NK cells, M1 macrophages, memory B cells, and follicular helper T cells were likely to be more prevalent in PCNSV samples. Naïve CD4 T cells and monocytes were mainly estimated to be present in GV and ABRA. Plasma cell and γδ T‐cell signatures were mainly found in LV and normal brain. GV showed higher levels of genes associated with macrophage activities and T cells. ABRA showed higher levels of long noncoding RNAs and miR‐616. LV showed higher levels of genes encoding immunoglobulins.InterpretationRNA sequencing confirmed PCNSV heterogeneity. ANN NEUROL 2023;93:120–130